CollPlant Biotechnologies (CLGN) Cash & Equivalents (2017 - 2026)
CollPlant Biotechnologies (CLGN) posted Cash & Equivalents of $2.56 million for the quarter ended Jun 30, 2026, down 77.6% from $11.43 million a year earlier.
Powered by 
Analysis
CollPlant Biotechnologies (CLGN) Cash & Equivalents (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, CollPlant Biotechnologies' Cash & Equivalents came in at $5.59 million, down 53.1% from the prior year.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 9.7% (years ended Dec 2020 to Dec 2025).
- In prior years, CollPlant Biotechnologies' Cash & Equivalents was $11.91 million in the year ended Dec 31, 2024 (-60.1%), $29.86 million in the year ended Dec 31, 2023 (+0.7%), $29.65 million in the year ended Dec 31, 2022 (+121.7%) and $13.37 million in the year ended Dec 31, 2021 (+279.3%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Cash & Equivalents since the quarter ended Jun 30, 2019.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was the quarter ended Sep 30, 2021, with growth of 397.9%; the weakest was the quarter ended Jun 30, 2026, with a decline of 77.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | CollPlant Biotechnologies | 4.57 Mn | -24.87 Mn | -456,000.00 | 2.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.56 Mn |
| Dec 31, 2025 | 5.59 Mn |
| Sep 30, 2025 | 8.55 Mn |
| Jun 30, 2025 | 11.43 Mn |
| Dec 31, 2024 | 11.91 Mn |
| Sep 30, 2024 | 15.37 Mn |
| Jun 30, 2024 | 18.92 Mn |
| Mar 31, 2024 | 23.23 Mn |
| Dec 31, 2023 | 29.86 Mn |
| Sep 30, 2023 | 28.98 Mn |
| Jun 30, 2023 | 22.37 Mn |
| Mar 31, 2023 | 26.79 Mn |
| Dec 31, 2022 | 13.37 Mn |
| Sep 30, 2022 | 33.02 Mn |
| Jun 30, 2022 | 36.50 Mn |
| Mar 31, 2022 | 41.29 Mn |
| Dec 31, 2021 | 13.15 Mn |
| Sep 30, 2021 | 25.97 Mn |
| Jun 30, 2021 | 17.68 Mn |
| Mar 31, 2021 | 19.91 Mn |
API Access
CollPlant Biotechnologies Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();